Company / Revenue
Bionano Genomics, Inc. Revenue History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$28.5M
FY2025
5-year range
$18.0M / $36.1M
FY2021-FY2025
Trend
-7.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $36M to $29M over the past 2 years.
Based on SEC 10-K filings.
$29M in FY2025 with a 5-year CAGR of +27.4%.
Declined from $36M to $29M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- +0.8%
- 5-Year CAGR
- +27.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +27.4%, indicating consistent growth.
- In FY2025, revenue decreased 7.4% year-over-year.
- Peak revenue was recorded in FY2023.
- Lowest revenue in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -8.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $28.5M | -7.4% |
| FY2024 | $30.8M | -14.8% |
| FY2023 | $36.1M | +29.9% |
| FY2022 | $27.8M | +54.6% |
| FY2021 | $18.0M | +111.5% |
| FY2020 | $8.5M | -16.1% |
| FY2019 | $10.1M | -15.6% |
| FY2018 | $12.0M | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 22, 2026